Jorge Conde
speaker
469 appearances
4 recordings
1 series
first heard Sep 2025
last heard 2 Sep
Jorge Conde’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Sep 2026 with 1.
Appearances
We're going to get a lot better at designing some of the more complex uh modalities, like the gene therapies of the world or the gene editors of the world.
And when you can do that and combine that with our ability to hopefully use things like virtual cell models to really understand what to go after.
Like we're gonna have drugs.
We I would hope and I would expect that the industry will continue to bring forward drugs that have very large effect size for very difficult diseases that hopefully affect a lot of patients.
If that's true, then we'll start to see some of these really, really difficult um diseases that affect all of society get tackled.
Hopefully, you know, one by one by one by one.
And so we have obesity, we have metabolic disorder, we're dealing with cardiometabolic.
disease.
We're starting to see interesting, promising things happening in like neurodegenerative diseases.
Um, you know, if we can, you know, tackle cancer or at least, you know, several cancers that now have begun to be treated more like a chronic condition than a death sentence that they were in the past.
The more we see of that, like I think that
Value to society will accrete over time, and I think.
This should be an industry that is extraordinarily uh valued by society and candidly by the markets.
We have to deliver.
Oh, I agree.
Yeah, yeah.
That that's the bottleneck.
You know, we we joke about it.
You have to do is you have to get a molecule that can go, you know, first in mice and then in muts and then in monkeys and then in man.
Like there's
Showing 421–440 of 469 · page 22 of 24
← Previous
Next →